Background*

Ms. Darlene M. Deptula-Hicks, M.B.A has been the Chief Financial Officer, Secretary and Treasurer of Pieris Pharmaceuticals, Inc. (formerly, Marika Inc) since December 17, 2014. Ms. Deptula-Hicks was a Financial Consultant to Pieris AG since November 19, 2014 and provided financial services relating to the Acquisition pursuant to a consulting agreement with the financial advisory firm of Danforth Advisors, LLC or Danforth. She served as an Acting Chief Financial Officer ... and Treasurer of Pieris and provided services through Danforth. Since June 2012, Ms. Deptula-Hicks served as an Executive Vice President and Chief Financial Officer of Microline Surgical, Inc., a surgical instruments and medical devices company. From September 11, 2006 to April 2011, Ms. Deptula-Hicks served as an Executive Vice President of Finance and Chief Financial Officer of iCAD, Inc. (Nasdaq: ICAD), a publicly traded medical device company and served as its Principal Accounting Officer and Secretary until April 2011 and Treasurer from September 2006 to April 2011. From 2002 to 2006 Ms. Deptula-Hicks served as an Executive Vice President and Chief Financial Officer of ONI Medical Systems, Inc., a venture capital-backed designer and manufacturer of high-field diagnostic imaging systems for orthopedic applications, and served as its Vice President. From 1998 to 2001, Ms. Deptula-Hicks served as an Executive Vice President and Chief Financial Officer of Implant Sciences Corporation (Amex:IMX), an early stage medical device company that had its initial public offering in June of 1999. She served as Vice President and Treasurer of Implant Sciences Corp. Prior to 1998, Ms. Deptula-Hicks held various senior financial and accounting positions at Abiomed, Inc., GCA Corporatio, Edwards High Vacuum International and Puritan Bennett Corporation. She has been a Director of Pieris Pharmaceuticals, Inc. since December 17, 2014. Ms. Deptula-Hicks has been a Non Executive Director of Xenetic Biosciences, Inc. (OTCBB:XBIO) since April 2014. Previously, Ms. Deptula-Hicks served as a Non Executive Director of Xenetic Biosciences, Inc. (OTCBB:XBIO) from 2006 to October 2014. She served as a Director of USfalcon, Inc. She served as an Independent Director of Technest Holdings, Inc. from March 15, 2006 to August 9, 2007 and IMCOR Pharmaceutical Co. since July 22, 2004. Ms. Deptula-Hicks received her B.S. in Accounting from Southern NH University and MBA from Rivier College.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.